DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
-9.11%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$377M
AUM Growth
+$377M
(-21%)
Cap. Flow
-$16.5M
Cap. Flow
% of AUM
-4.38%
Top 10 Holdings %
Top 10 Hldgs %
50.73%
Holding
91
New
7
Increased
20
Reduced
15
Closed
11
Top Buys
| 1 |
Cytokinetics
CYTK
|
$6.26M |
| 2 |
IDEAYA Biosciences
IDYA
|
$3.27M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$2.64M |
| 4 |
Alector
ALEC
|
$2.45M |
| 5 |
KalVista Pharmaceuticals
KALV
|
$2.24M |
Top Sells
| 1 |
Theravance Biopharma
TBPH
|
$10.6M |
| 2 |
TBIO
Translate Bio, Inc. Common Stock
TBIO
|
$10.4M |
| 3 |
ProQR Therapeutics
PRQR
|
$6.16M |
| 4 |
LMNX
Luminex Corp
LMNX
|
$5.12M |
| 5 |
TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
|
$4.5M |
Sector Composition
| 1 | Healthcare | 91.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISEE
26
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $3.51M | 0.93% |
216,351
+36,400
| +20% | +$591K |
|
|
27
KalVista Pharmaceuticals
KALV
$713M
| $3.3M | 0.88% |
189,163
+128,563
| +212% | +$2.24M |
|
|
AERI
28
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $3.3M | 0.87% |
289,040
| – | – |
|
|
PRDS
29
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $2.99M | 0.79% |
299,950
-50
| -0% | -$498 |
|
30
Adicet Bio
ACET
$60.8M
| $2.95M | 0.78% |
376,281
| – | – |
|
31
Rigel Pharmaceuticals
RIGL
$710M
| $2.94M | 0.78% |
80,900
+56,500
| +232% | +$2.05M |
|
32
Merus
MRUS
$5.04B
| $2.9M | 0.77% |
131,949
-25,892
| -16% | -$570K |
|
33
Viking Therapeutics
VKTX
$3.02B
| $2.81M | 0.75% |
447,400
| – | – |
|
34
Venus Concept
VERO
$4.07M
| $2.79M | 0.74% |
6,747
-435
| -6% | -$180K |
|
|
TPTX
35
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $2.79M | 0.74% |
41,952
-5,900
| -12% | -$392K |
|
|
KDMN
36
DELISTED
Kadmon Holdings, Inc.
KDMN
| $2.74M | 0.73% |
314,561
-80,000
| -20% | -$697K |
|
|
MREO
37
Mereo BioPharma
MREO
$275M
| $2.73M | 0.72% |
1,126,613
| – | – |
|
38
89bio
ETNB
$1.37B
| $2.48M | 0.66% |
126,652
+10,200
| +9% | +$200K |
|
|
39
ProQR Therapeutics
PRQR
$256M
| $2.48M | 0.66% |
296,383
-735,497
| -71% | -$6.16M |
|
|
40
Alector
ALEC
$282M
| $2.45M | 0.65% |
+107,412
| New | +$2.45M |
|
|
KNTE
41
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $2.45M | 0.65% |
106,453
+52,038
| +96% | +$1.2M |
|
|
NTUS
42
DELISTED
Natus Medical Inc
NTUS
| $2.4M | 0.64% |
95,653
| – | – |
|
|
ITOS
43
DELISTED
iTeos Therapeutics
ITOS
| $2.24M | 0.6% |
+83,061
| New | +$2.24M |
|
44
Neuronetics
STIM
$208M
| $2.06M | 0.55% |
313,717
+60,000
| +24% | +$394K |
|
45
Century Therapeutics
IPSC
$40.4M
| $2.01M | 0.53% |
80,000
| – | – |
|
|
CBAY
46
DELISTED
Cymabay Therapeutics
CBAY
| $1.91M | 0.51% |
524,286
+13,900
| +3% | +$50.7K |
|
|
HOOK
47
DELISTED
HOOKIPA Pharma
HOOK
| $1.9M | 0.5% |
32,212
| – | – |
|
48
Kura Oncology
KURA
$732M
| $1.89M | 0.5% |
100,829
+17,300
| +21% | +$324K |
|
49
MacroGenics
MGNX
$121M
| $1.89M | 0.5% |
+90,000
| New | +$1.89M |
|
50
Cogent Biosciences
COGT
$1.83B
| $1.88M | 0.5% |
223,554
| – | – |
|